drugset / Trial / NCT02093468
Evaluation of MST-188 in Acute Lower Limb Ischemia
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of MST-188 in subjects receiving catheter-directed rt-PA for acute lower limb ischemia and to evaluate whether treatment with MST-188 results in more rapid thrombolysis of the occlusion and more rapid tissue perfusion in the effected blood vessel.
Timeline
- Start
- 2014-06
- Primary completion
- 2016-12
- Completion
- —
Outcome
Outcome not reported
Stopped: “Program discontinued to persue alternate indications.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vepoloxamer | Small molecule | 25 mg/kg | Intravenous |
| Subject | Vepoloxamer | Small molecule | 75 mg/kg | Intravenous |